Citations

Clear

139 citation(s) found for "Ziegelmann, Matthew".

Reverberant wavefield characterization and directional filtering for penile vibro-elastography: a pilot feasibility study in post-prostatectomy erectile dysfunction
Bui, Ngoc Thang , Ziegelmann, Matt, Kohler, Tobias S , Zhang, Xiaoming , Ziegelmann, Matthew , Zhang, Xiaoming , Köhler, Tobias

Mayo Clinic

Physics in Medicine & Biology | June 12, 2026 | Volume: 71 | Issue: 12 | Pages: 125039

10.1088/1361-6560/ae7cd7 | PMID 42285148 Get It

Abstract Objective . Penile vibro-elastography (PVE) is complicated by reverberant shear wavefields from the cylindrical geometry of the corpus cavernosum (CC), which bias shear wave speed (SWS) estimates. This study evaluated local phase velocity imaging with wavefield-based filtering (LPVI-WBF) for CC stiffness assessment in post-prostatectomy erectile dysfunction (ED), compared against phase gradient (PG) and time-of-flight (TOF) methods. Approach . Six patients with post-prostatectomy ED underwent PVE at four longitudinal visits (902 acquisitions). SWS was estimated in flaccid and erect states at 100, 150, and 200 Hz using LPVI-WBF, PG, and TOF. Wavefield composition was quantified via the standing wave index. Simulations evaluated accuracy and frequency stability under clean and reverberant conditions. Main results . Reverberant components dominated penile acquisitions, with traveling wave energy absent in 59% of acquisitions and mean standing wave fraction of 57 ± 17%. LPVI-WBF was the only method producing physiologically consistent estimates, with erect SWS exceeding flaccid (3.59 ± 0.48 vs 3.25 ± 0.58 m s −1 , p < 0.0001). PG and TOF yielded reversed results ( E < F, p < 0.0001). The dispersion exponent was near-zero for LPVI-WBF ( α = 0.048, p = 0.21), consistent with weakly viscoelastic tissue, while PG ( α = 0.184) and TOF ( α = 0.321) showed significant frequency dependence from reverberant contamination. Simulations confirm PG accuracy in clean wavefields but collapse under reverberant ones. Significance . LPVI-WBF produced SWS estimates consistent with expected CC biomechanics across all patients and frequencies, a criterion PG and TOF failed to satisfy. Phantom validation and multi-directional wavefield simulation are needed to establish accuracy.
Industry payments by drug and medical device manufacturers to Sexual Medicine Society of North America fellowship program directors
Kim, Tae-Hee , Gross, M, Köhler, Tobias , Ziegelmann, M, Gross, Martin , Ziegelmann, Matthew J, Helo, Sevann , Kim, Tae-Hee , Ziegelmann, Matthew

Mayo Clinic

The Journal of Sexual Medicine | June 9, 2026 | Volume: 23 | Issue: 7 | Pages: No page available

10.1093/jsxmed/qdag196 | PMID 42348864 Get It

(236) Multicenter Evaluation on the Use of Down-Sized Cylinders in Penile Prosthesis Surgery
Chawareb, E Abou, Lee, J, Campos, L, Hammad, M Moukhtar, Miller, J, Azad, B, Swerdloff, D, Osmonov, D, Sadeghi-Nejad, H, Burnett, A, Pearce, I, Lentz, A, Modgil, V, Warner, J N, Ziegelmann, M, Jr., A Suarez-Sarmiento, Perito, P, Simhan, J, Gross, M, Yafi, F A, Barham, D, Hammad, Muhammed , Azad, Babak Kazemzadeh , Swerdloff, Daniel , Sadeghi‐Nejad, Hossein , Burnett, Arthur L. “Bud” , Pearce, Ian , Lentz, A, Modgil, Vaibhav , Ziegelmann, Matthew , Suarez‐Sarmiento, Alfredo, Perito, P, Simhan, Jay , Barham, David W.

Mayo Clinic

The Journal of Sexual Medicine | June 4, 2026 | Volume: 23 | Issue: Supplement_4 | Pages: No page available

10.1093/jsxmed/qdag118.217 Get It

Abstract Introduction Down-sized inflatable penile prosthesis (IPP) cylinders are used in challenging penile fibrosis scenarios, such as after priapism or prior implant infection. Their role in primary penile prosthesis surgery, however, is not well studied. Objective This study aims to identify factors associated with the use of down-sized cylinders in men undergoing primary IPP placement. Methods We conducted a multicenter, retrospective study on men undergoing primary IPP surgery, categorizing them into a down-sized cylinder group (AMS 700 CXR and Coloplast NB) and a standard cylinder group (AMS 700 CX, AMS 700 LGX, and Coloplast Titan). We collected demographic, intraoperative, and postoperative variables and performed a multivariable analysis. Results 4,389 men were included in the study with a mean age of 62.3±10.3 years. Overall, 1,485 (34%) men had diabetes, and 2,131 (49%) had hypertension. Down-sized cylinders were placed in 406 men (174 CXRs, 232 NBs), while standard cylinders were placed in 3,983. Multivariable analysis indicated that down-sized cylinders were more commonly used in men with diabetes (OR 2.6 [1.9, 3.7], p&lt;0.001) and less frequently in men with hypertension (OR 0.5 [0.4, 0.7], p&lt;0.001). A history of priapism did not significantly impact the use of down-sized cylinders (p≥0.152). Sequential dilation was performed more often with the use of down-sized cylinders (OR 4.0 [2.8, 5.7], p&lt;0.001). Down-sized cylinders were associated with an increased rate of non-infectious complications (OR 1.9 [1.3, 2.9], p&lt;0.001), however, there was no significant association with implant infection (OR 2.1 [0.9, 4.6], p=0.07). Non-infectious complications occurred in 44 (25%) men with down-sized cylinders. In the down-sized group, hematomas occurred in 10 (2.5%) men and wound-related complications occurred in 7 (1.7%) men (Table 1). Cylinder-related complications occurred in 7 (1.7%) men with down-sized cylinders. Device-related malfunctions were seen in 8 (2%) men. Conclusions This study demonstrates that down-sized cylinders are more frequently used in men with diabetes and surgeons should be prepared to place down-sized cylinders in these men. Prosthetic urologists are also more likely to use down-sized cylinders in men requiring sequential dilation likely due to fibrosis or more challenging dilations. Down-sized cylinders are associated with a low overall complication rate. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Intuitive Surgical, Fidelis, Urofill, Boston Scientific, Coloplast, Cynosure, Antares Pharma, Clarus Pharmaceuticals, Acerus Pharma; Endo Pharma.
Anabolic androgenic steroid content on social media: reliability, engagement, and public health implications
Lozoya, Andres H Guillen, Hashemi, Milad Bonakdar , Cerda, Brenda Bolanos, Ziegelmann, Matthew J, Köhler, Tobias S, Lozoya, Andres Guillen , Bonakdar Hashemi, Milad, Helo, Sevann , Ziegelmann, Matthew J.

Mayo Clinic

The Journal of Sexual Medicine | April 16, 2026 | Volume: 23 | Issue: 5 | Pages: No page available

10.1093/jsxmed/qdag126 | PMID 42070119 Get It

Defining clinically relevant responses in erectile function: an SMSNA position statement
Trost, Landon , Yafi, Faysal, Shindel, A.W. , Khera, Mohit, Rosen, Raymond C., Bajic, Petar , Bernie, Helen, Gross, Martin , Hannan, Johanna L. , Jenkins, Lawrence C. , Watter, Daniel , Ziegelmann, Matthew , Köhler, T, Helo, Sevann , Jenkins, Lawrence , Watter, Daniel , Khera, Mohit , Podlasek, Carol A.

Mayo Clinic

The Journal of Sexual Medicine | December 24, 2025 | Volume: 23 | Issue: 3 | Pages: No page available

10.1093/jsxmed/qdaf392 | PMID 41785054 Get It

Abstract Background To date, no scoring system has adequately defined clinical efficacy of erectile dysfunction (ED) therapies when evaluating differences between cohorts or in meta-analytic studies. Aim To outline the minimal criteria required for any therapy to be considered clinically effective in the treatment of ED. Methods An analytic review was performed of standardized ED questionnaires, with a particular emphasis placed on the International Index of Erectile Function, Erectile Function Domain (IIEF-EFD), and the minimally clinically important difference (MCID) concept. The data were used to create a societal position statement and recommendations on best practices within clinical trials to determine treatment efficacy. Outcomes The SMSNA provided 6 key statements and recommendations to suggest best practices and define minimal thresholds for improvements required for an ED therapy to be considered clinically effective. Results The IIEF-EFD currently represents the preferred standardized questionnaire to evaluate for changes in erectile function post-treatment and is the only questionnaire adequate to assess primary outcomes. To claim efficacy, investigational treatments must demonstrate MCID between cohorts (eg, 2-, 5-, or 7-point median improvements between groups among mild, moderate, or severe ED cohorts) in prospective, randomized, placebo-controlled, and adequately powered studies. In studies employing mixed-severity ED populations, a method of calculating an adjusted MCID was proposed based on statistical weighting principles. Similarly, a novel method for analyzing differences between cohorts in meta-analytic studies was presented to incorporate the concept of MCID. Based on these principles, the SMSNA would not support efficacy of a therapy based on statistical significance in a meta-analytic study alone. Similarly, studies claiming efficacy utilizing responder approaches (ie, statistically higher percentage of men achieving MCID between cohorts) would not be acceptable unless the median difference between groups on the IIEF-EFD achieved MCID. Clinical Implications The current position statement provides important, evidence-based data and scientific principles to help define what may be considered as an effective therapy in the treatment of ED. This framework provides a basis that decision-makers, clinicians, and patients may use to help differentiate clinically effective therapies. Strengths & Limitations The published literature is limited by a lack of validated instruments and data defining MCID for ED therapies between cohorts and with meta-analytic studies. The current position statement provides important guidance on these areas of ambiguity pending further, definitive data. Conclusion The current position statement provides detailed guidance on key criteria required to conclude efficacy of therapies used to treat ED.
Office-based penile plication with ring block: a safe and effective alternative to operating room–based surgery
Premo, Hayley, Parikh, Niki , Ali, Hanin, Tentis, E, Ziegelmann, Matthew , Tentis, Elise, Kohler, Tobias S , Premo, Hayley , Yang, David Y.

Mayo Clinic

The Journal of Sexual Medicine | December 24, 2025 | Volume: 23 | Issue: 2 | Pages: No page available

10.1093/jsxmed/qdaf396 | PMID 41563061 Get It

Evaluation of advertised medical school preclinical urology and sexual education curricula in the north central section of the American Urological Association
Schrup, Sarah E. , Vencill, Jennifer A. , Ziegelmann, Matthew , Dumbravă, Mihai

Mayo Clinic

The Journal of Sexual Medicine | December 19, 2025 | Volume: 23 | Issue: 2 | Pages: No page available

10.1093/jsxmed/qdaf388 | PMID 41504416 Get It

(321) Tied up With Trouble: Suture Sling Shenanigans
Honda, B, Ziegelmann, Matthew , Kohler, T, Honda, B, Cohen, T, Helo, Sevann , Kohler, T

Mayo Clinic

The Journal of Sexual Medicine | December 9, 2025 | Volume: 22 | Issue: Supplement_4 | Pages: No page available

10.1093/jsxmed/qdaf320.317 Get It

Abstract Introduction Proximal perforation in complex penile prosthesis placement is well recognized. If recognized, suture sling repair amongst other techniques is our favored approach. Unrecognized proximal perforation often results in unilateral or bilateral perineal bruising, often with eventual proximal device migration and palpability of the proximal device in the buttock. Objective We present a series of 5 cases in which the suture sling technique was utilized for known proximal perforation, with subsequent need for immediate or delayed revision. Methods We assessed all cases performed at Mayo Clinic since 2018 that resulted in a known suture sling complication amongst 3 high volume implanters. We identified 5 cases in which the suture sling technique required revision surgery. All patients underwent cross sectional imaging for further evaluation. Results Patients were males aged 59 to 89 with erectile dysfunction. There were no consistent factors amongst the 5 cases that may have predicted suture sling complication. The majority of cases were inflatable penile prostheses (4/5), were prosthesis revision cases (3/5), utilized the penoscrotal approach (4/5), were Coloplast devices (4/5), utilized rear tip extenders (3/5), utilized Prolene suture sling (3/5), and returned to OR within 2 days for revision (3/5). The majority of the complications (4/5) involved excessive proximal cylinder length that were palpable on examination of the buttocks or near the rectum (one felt on rectal exam). One case demonstrated improper anchoring of the device not allowing proximal seating and thus S shaped deformity. We noted medial cylinder deviation on all imaging, as corporal perforation was always medial to the true corporal path. Conclusions When performing suture slings, surgeons should be very wary of oversizing. The medial cylinder path and prior surgical capsule may mislead surgeons when choosing appropriate cylinder length. If perforated, we advocate against rear tips and for under sizing in general, as proximal anchoring is reliant upon the suture, not a true corporal boundary. Similarly, the device should be fully inflated and proximally seated on palpation prior to tying down the sling to avoid S deformities. Disclosure No